Apr 23, 2019 / 08:00AM GMT
Operator
Good morning, ladies and gentlemen, thank you for standing by, and welcome to the Vitrolife Interim Report January to March 2019 (Operator Instructions) I'd now like -- I must advise you, sorry, the conference is being recorded today, Tuesday, the 23rd of April 2019.
I would now like to hand the conference over to your first speaker today, Thomas Axelsson. Please, go ahead.
Thomas Axelsson - Vitrolife AB(publ)-CEO
Thank you very much, and welcome to Vitrolife Interim Report January-March 2019. The speakers today will be Mikael Engblom, CFO of Vitrolife; and myself, Thomas Axelsson, the CEO of Vitrolife.
So please go to page number 2 and we'll go through the summary of Q1. The Q1, for us, was a quarter with continuous high profitability and I would also like to comment that we had a new business unit for this quarter. So sales was SEK 312 million and it's a growth of 18%. The sales increase was 12% in local currency, where 4% was organic growth. EBITDA 40% margin and totaled SEK 126 million.
During
Q1 2019 Vitrolife AB Earnings Call Transcript
Apr 23, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers